Nashville, TN, United States of America

Sekhar R Konjeti

This inventor holds 1 USPTO granted patent. Top assignees: University of Kentucky Research Foundation, Vanderbilt University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sekhar R Konjeti. Retrieved from https://idiyas.com/inventor/sekhar-r-konjeti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sekhar R Konjeti: Innovator in Cancer Treatment

Introduction

Sekhar R Konjeti is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of indole compounds. His work focuses on enhancing the effectiveness of chemotherapeutic agents and radiosensitizing agents.

Latest Patents

Sekhar R Konjeti holds a patent for "Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents." This patent highlights the development of indole derivatives that are beneficial in treating cancer, serving as both chemotherapeutic and radiosensitizing agents. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Sekhar has worked with prestigious institutions such as Vanderbilt University and the University of Kentucky Research Foundation. His research has contributed to the understanding and treatment of cancer, making a lasting impact in the medical community.

Collaborations

Sekhar has collaborated with esteemed colleagues, including Thirupathi Reddy Yerramreddy and Narsimha R Penthala. These partnerships have furthered his research efforts and expanded the scope of his work in cancer treatment.

Conclusion

Sekhar R Konjeti is a dedicated inventor whose work in developing indole compounds has the potential to revolutionize cancer treatment. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…